Cell proliferation in skin tumors with ductal differentiation: Patterns and diagnostic applications

Journal of Cutaneous Pathology

Volumn 27, Issue 6, 2000, Pages 292-297

  Pozo, Lucia ^a,b   Camacho, Francisco ^b   Rios Martin, Juan J ^b   Diaz Cano, Salvador J ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER SCREENING; CELL HETEROGENEITY; CELL PROLIFERATION; CONTROLLED STUDY; CYLINDROMA; FEMALE; HIDRADENOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROSCOPY; MITOSIS RATE; SKIN CARCINOMA; SKIN TUMOR; SYRINGOMA; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

ACROSPIROMA, ECCRINE; ADENOMA, SWEAT GLAND; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MITOTIC INDEX; NUCLEAR PROTEINS; SWEAT GLAND NEOPLASMS; SYRINGOMA;

EID: 0034080515     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2000.027006292.x     Document Type: Article

References (24)

1. 1. Ansai S, Koseki S, Hozumi Y, Kondo S. Assessment of cellular proliferation of eccrine acrospiromas and eccrine sweat gland carcinomas by AgNOR counting and immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) and Ki-67. Clin Exp Dermatol 1995; 20: 27.
2. 2. Cooper PH. Mitotic figures in sweat gland adenomas. J Cutan Pathol 1987; 14: 10.
3. 3. van Diest PJ, Baak JP, Matze-Cok P, et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 1992; 23: 603.
4. 4. Collan Y, Haapasalo H. The value of mitotic counting in the assessment of prognosis and proliferation in human tumours. J Pathol 1991; 163: 361.
5. 5. Meyer JS. Cell kinetic measurements of human tumors. Hum Pathol 1982; 13: 874.
6. 6. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: Evaluation of methods and applications as prognostic variables. J Pathol 1990; 160: 93.
7. 7. Tham KT. Estimation of mitotic count in tumors. Hum Pathol 1992; 23: 1313.
8. 8. Simpson JF, Dutt PL, Page DL. Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol 1992; 23: 608.
9. 9. Wick MR, Goellner JR, Wolfe JTd, Su WP. Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer 1985; 56: 1147.
10. 10. Wong TY, Suster S, Nogita T, Duncan LM, Dickersin RG, Mihm MC Jr. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients. Cancer 1994; 73: 1631.
11. 11. Shaw M, McKee PH, Lowe D, Black MM. Malignant eccrine poroma: a study of twenty-seven cases. Br J Dermatol 1982; 107: 675.
12. 12. Murphy GF, Elder DE. Non-melanocytic tumors of the skin. Washington, D.C.: Armed Forces Institute of Pathology, 1991.
13. 13. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710.
14. 14. Diaz-Cano SJ, Leon MM, de Miguel M, Galera Davidson H, Wolfe HJ. Mitotic index quantification: Different approaches and their value in adrenocortical proliferative lesions. Lab Invest 1996; 74: 170A.
15. 15. Schmiegelow P, Schroiff R, Breitbart E, Bahnsen J, Lindner J, Jänner M. Malignant melanoma Its precursors and its topography of proliferation. DNA-Feulgen-cytophotometry and mitosis index. Virchows Arch 1986; 409: 47.
16. 16. Blanes A, Marquez A, Sanchez-Carrillo JJ, Matilla A, Diaz-Cano SJ. Proliferative features by tumor cell compartment in skin malignant melanomas. J Pathol 1999; 187 (Suppl): 23A.
17. 17. Blanes A, Rubio J, Martinez A, Matilla A, Diaz-Cano SJ, Wolfe HJ. Kinetic profile by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Lab Invest 1999; 79: 90A.
18. 18. Diaz-Cano SJ, Blanes A, Rubio J, Matilla A, Wolfe HJ. Topographic profile in muscle-invasive transitional cell carcinomas of the urinary bladder: Differential generic and kinetic patterns. Lab Invest 1998; 78: 80A.
19. 19. Diaz-Cano SJ, Blanes A, Rubio J, Matilla A, Wolfe HJ. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Lab Invest 2000; in press.
20. 20. Gorunova L, Mertens F, Mandahl N, et al. Cytogenetic heterogeneity in a clear cell hidradenoma of the skin. Cancer Genet Cytogenet 1994; 77: 26.
21. 21. Wohlfahrt C, Ternesten A, Sahlin P, Islam Q, Stenman G. Cytogenetic and fluorescence in situ hybridization analyses of a microcystic adnexal carcinoma with del(6)(q23q25). Cancer Genet Cytogenet 1997; 98: 106.
22. 22. Kakinuma H, Miyamoto R, Iwasawa U, Baba S, Suzuki H. Three subtypes of poroid neoplasia in a single lesion: eccrine poroma, hidroacanthoma simplex, and dermal duct tumor. Histologic, histochemical, and ultrastructural findings. Am J Dermatopathol 1994; 16: 66.
23. 23. Pozo L. Tumores ecrinos: Correlacion clinico-patologica. Estudios histopatologico e inmunohistoquimico. Evolucion pronostica. Doctoral thesis, University of Seville, Seville, Spain, 1996.
24. 24. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991; 19: 403.